Detalhe da pesquisa
1.
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype.
Clin Immunol
; 254: 109684, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451415
2.
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
N Engl J Med
; 382(4): 341-352, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971679
3.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Ophthalmology
; 129(4): 438-449, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688699
4.
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review.
Int J Mol Sci
; 23(21)2022 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362236
5.
Teprotumumab for Thyroid-Associated Ophthalmopathy.
N Engl J Med
; 376(18): 1748-1761, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467880
6.
Combined immunosuppressants and less steroids in active graves' orbitopathy?
Clin Endocrinol (Oxf)
; 90(4): 525-527, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30549306
7.
Tocilizumab for thyroid eye disease.
Cochrane Database Syst Rev
; 11: CD012984, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30480323
8.
Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination.
J Clin Endocrinol Metab
; 109(2): 516-526, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622279
9.
Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.
Eur Thyroid J
; 13(2)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471303
10.
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
Br J Ophthalmol
; 108(2): 294-300, 2024 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627174
11.
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.
Ophthalmology
; 120(5): 1092-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23399378
12.
Long-term outcome of thyroid abnormalities in patients with severe Covid-19.
Eur Thyroid J
; 12(2)2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715690
13.
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression.
Thyroid
; 33(6): 743-751, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140534
14.
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study.
J Clin Endocrinol Metab
; 108(8): 2065-2077, 2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683389
15.
Future Projections in Thyroid Eye Disease.
J Clin Endocrinol Metab
; 107(Suppl_1): S47-S56, 2022 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346684
16.
Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Eur Thyroid J
; 11(6)2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479875
17.
Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Thyroid
; 32(12): 1439-1470, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480280
18.
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy.
Thyroid
; 31(5): 821-828, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234032
19.
Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
Thyroid
; 31(2): 280-287, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940167
20.
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy.
Front Endocrinol (Lausanne)
; 12: 790246, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145479